2,6-dimethyl-3,4-dihydro-1H-[1]benzothiolo[2,3-c]pyridine | 1240603-16-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻吩类
• 英文名称: 2,6-dimethyl-3,4-dihydro-1H-[1]benzothiolo[2,3-c]pyridine
• CAS: 1240603-16-0
• 化学式: C₁₃H₁₅NS
• 分子量: 217.335
• InChiKey: FPCXHJLROSXGBO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  31.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2,6-dimethyl-3,4-dihydro-1H-[1]benzothiolo[2,3-c]pyridine 、 丁炔二酸二甲酯 以 乙腈 为溶剂， 以20%的产率得到dimethyl 1',5-dimethyl-2-methylene-5',6'-dihydro-1'H-spiro[1-benzothiophene-3,4'-pyridine]-2',3'-dicarboxylate
  参考文献：
  名称：

  通过苯并噻吩并[2,3-c]吡啶与乙炔二羧酸酯的反应形成螺并[苯并噻吩并-3,4'-吡啶]

  摘要：

  DOI：

  10.1007/s10593-010-0514-1

文献信息

• Tandem transformations of tetrahydrobenzothieno[2,3-c]pyridines in the presence of activated alkynes
  作者：Leonid G. Voskressensky、Svetlana A. Kovaleva、Tatiana N. Borisova、Anna V. Listratova、Alexandr B. Eresko、Valery S. Tolkunov、Sergey V. Tolkunov、Alexey V. Varlamov

  DOI：10.1016/j.tet.2010.09.098

  日期：2010.11

  The reactivity of some new tetrahydrothienopyridines towards activated alkynes was investigated. A novel cascade cleavage-spiroannulation process, leading to the formation of previously unreported derivatives of 1'H-spiro[1-benzothiophene-3,4'-pyridine] was discovered and studied. (C) 2010 Elsevier Ltd. All rights reserved.
• 1, 4-DISUBSTITUTED 3-CYANO-PYRIDONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS
  申请人：Imogai Hassan Julien

  公开号：US20100166655A1

  公开（公告）日：2010-07-01

  The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I) wherein all radicals are defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic receptors-subtype 2 (“mGluR2”) which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.
• 1, 4-Disubstituted 3-Cyano-Pyridone Derivatives and Their Use As Positive Allosteric Modulators of MGLUR2-Receptors
  申请人：JANSSEN PHARMACEUTICALS, INC.

  公开号：US20140315903A1

  公开（公告）日：2014-10-23

  The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I) wherein all radicals are defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic receptors—subtype 2 (“mGluR2”) which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.
• US8841323B2
  申请人：——

  公开号：US8841323B2

  公开（公告）日：2014-09-23
• US9266834B2
  申请人：——

  公开号：US9266834B2

  公开（公告）日：2016-02-23